216 related articles for article (PubMed ID: 25392238)
41. 2018 White Paper on Recent Issues in Bioanalysis: 'A global bioanalytical community perspective on last decade of incurred samples reanalysis (ISR)' (Part 1 - small molecule regulated bioanalysis, small molecule biomarkers, peptides & oligonucleotide bioanalysis).
Welink J; Xu Y; Yang E; Wilson A; Henderson N; Luo L; Fraser S; Kavita U; Musuku A; James C; Fraier D; Zhang Y; Goykhman D; Summerfield S; Woolf E; Verhaeghe T; Hughes N; Behling A; Brown K; Bulychev A; Buonarati M; Cherry E; Cho SJ; Cludts I; Dillen L; Dodge R; Edmison A; Garofolo F; Green R; Haidar S; Hottenstein C; Ishii-Watabe A; Jang HG; Ji A; Jones B; Kassim S; Ma M; Lima Santos GM; Norris DA; Owen T; Piccoli S; Ramanathan R; Röhl I; Rosenbaum AI; Saito Y; Sangster T; Savoie N; Stebbins C; Sydor J; de Merbel NV; Verthelyi D; Vinter S; Whale E
Bioanalysis; 2018 Nov; 10(22):1781-1801. PubMed ID: 30488725
[TBL] [Abstract][Full Text] [Related]
42. Bioanalysis of farnesyl pyrophosphate in human plasma by high-performance liquid chromatography coupled to triple quadrupole tandem mass spectrometry and hybrid quadrupole Orbitrap high-resolution mass spectrometry.
Sugimoto H; Iguchi M; Jinno F
Anal Bioanal Chem; 2017 May; 409(14):3551-3560. PubMed ID: 28343347
[TBL] [Abstract][Full Text] [Related]
43. Non-regulated LC-MS/MS bioanalysis in support of early drug development: a Novartis perspective.
Fu Y; Li W; Picard F
Bioanalysis; 2023 Feb; 15(3):109-125. PubMed ID: 36976931
[TBL] [Abstract][Full Text] [Related]
44. Quantitative evaluation of the matrix effect in bioanalytical methods based on LC-MS: A comparison of two approaches.
Rudzki PJ; Gniazdowska E; Buś-Kwaśnik K
J Pharm Biomed Anal; 2018 Jun; 155():314-319. PubMed ID: 29684812
[TBL] [Abstract][Full Text] [Related]
45. Validation and application of hybridization liquid chromatography-tandem mass spectrometry methods for quantitative bioanalysis of antisense oligonucleotides.
Li P; Dupuis JF; Vrionis V; Mekhssian K; Magee T; Yuan L
Bioanalysis; 2022 May; 14(9):589-601. PubMed ID: 35545949
[No Abstract] [Full Text] [Related]
46. Method development workflow for quantifying protein biomarkers by hybrid LC-MS/MS.
Agrawal K; Shi Y; Del Rosario AM; Jian W
Bioanalysis; 2022 Jul; 14(14):985-1004. PubMed ID: 36066044
[No Abstract] [Full Text] [Related]
47. Bioanalysis of therapeutic monoclonal antibody by peptide adsorption-controlled LC-MS.
Hashii N; Tousaka Y; Arai K; Enoki Y; Fukuda S; Goda R; Inoue N; Kawabata M; Murata K; Nakatsuji M; Okuzono T; Shigeyama T; Tachiki H; Yamaguchi T; Yamane S; Yamaoka M; Saito Y; Ishii-Watabe A
Bioanalysis; 2021 Feb; 13(4):265-276. PubMed ID: 33543661
[No Abstract] [Full Text] [Related]
48. Validation of a biotherapeutic immunoaffinity-LC-MS/MS assay in monkey serum: 'plug-and-play' across seven molecules.
Kaur S; Liu L; Cortes DF; Shao J; Jenkins R; Mylott WR; Xu K
Bioanalysis; 2016 Aug; 8(15):1565-1577. PubMed ID: 27396481
[TBL] [Abstract][Full Text] [Related]
49. A strategy for liquid chromatography/tandem mass spectrometry based quantitation of pegylated protein drugs in plasma using plasma protein precipitation with water-miscible organic solvents and subsequent trypsin digestion to generate surrogate peptides for detection.
Wu ST; Ouyang Z; Olah TV; Jemal M
Rapid Commun Mass Spectrom; 2011 Jan; 25(2):281-90. PubMed ID: 21192023
[TBL] [Abstract][Full Text] [Related]
50. Strategies for effective development of ultra-sensitive LC-MS/MS assays: application to a novel STING agonist.
Fang K; Licea-Perez H
Bioanalysis; 2020 Apr; 12(7):467-484. PubMed ID: 32343151
[No Abstract] [Full Text] [Related]
51. Anticoagulant counter ion impact on bioanalytical LC-MS/MS assays: results from discussions and experiments within the European Bioanalysis Forum.
Sennbro CJ; Knutsson M; van Amsterdam P; Timmerman P
Bioanalysis; 2011 Nov; 3(21):2393-9. PubMed ID: 22074281
[TBL] [Abstract][Full Text] [Related]
52. An automation-assisted generic approach for biological sample preparation and LC-MS/MS method validation.
Zhang J; Wei S; Ayres DW; Smith HT; Tse FL
Bioanalysis; 2011 Sep; 3(17):1975-86. PubMed ID: 21899506
[TBL] [Abstract][Full Text] [Related]
53. Comparison of methods for quantitative analysis of ranibizumab and bevacizumab in human plasma using various bioanalytical techniques, including microfluidic immunoassay, triple quadrupole, and high-resolution liquid chromatography-tandem mass spectrometry approaches.
DelGuidice CE; Ismaiel OA; Mylott WR; Halquist MS
J Pharm Biomed Anal; 2022 Aug; 217():114823. PubMed ID: 35576733
[TBL] [Abstract][Full Text] [Related]
54. Development and validation of an LC-MS/MS based quantitative assay for marmoset insulin in serum.
Goy RW; Shrestha HK; Colman RJ; Dukes NJ; Ziegler TE; Kapoor A
J Chromatogr B Analyt Technol Biomed Life Sci; 2022 Apr; 1195():123150. PubMed ID: 35247678
[TBL] [Abstract][Full Text] [Related]
55. Fit-for-purpose protein biomarker assay validation strategies using hybrid immunocapture-liquid chromatography-tandem-mass spectrometry platform: Quantitative analysis of total soluble cluster of differentiation 73.
Zhao Y; Gu H; Postelnek J; DeMichele M; Yuan L; Zhang YJ; Zeng J
Anal Chim Acta; 2020 Aug; 1126():144-153. PubMed ID: 32736718
[TBL] [Abstract][Full Text] [Related]
56. Critical reagent screening and characterization: benefits and approaches for protein biomarker assays by hybrid LC-MS.
Santockyte R; Zeng J; Zheng N
Bioanalysis; 2019 Apr; 11(8):785-795. PubMed ID: 30994008
[TBL] [Abstract][Full Text] [Related]
57. Bioanalytical method development and validation of highly selective and sensitive LC-MS/MS method for determination of teriparatide (parathyroid hormone fragment 1-34) in human serum through direct detection of intact teriparatide molecule.
Kusuma MB; Kashibhatta R; Gavande A; Kiran R; Jagtap S; Vithala P; Moorkoth S; Bhat K
J Chromatogr B Analyt Technol Biomed Life Sci; 2021 Dec; 1187():123046. PubMed ID: 34823096
[TBL] [Abstract][Full Text] [Related]
58. Protein quantification by LC-MS: a decade of progress through the pages of
van de Merbel NC
Bioanalysis; 2019 Apr; 11(7):629-644. PubMed ID: 30983409
[TBL] [Abstract][Full Text] [Related]
59. Development of a surrogate matrix for cerebral spinal fluid for liquid chromatography/mass spectrometry based analytical methods.
Hooshfar S; Basiri B; Bartlett MG
Rapid Commun Mass Spectrom; 2016 Apr; 30(7):854-8. PubMed ID: 26969926
[TBL] [Abstract][Full Text] [Related]
60. Dried blood spots as a sampling technique for the quantitative determination of guanfacine in clinical studies.
Li Y; Henion J; Abbott R; Wang P
Bioanalysis; 2011 Nov; 3(22):2501-14. PubMed ID: 22122599
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
